title: Interaction of granulocytopenia and construction activity as risk factors for nosocomial invasive filamentous fungal disease in patients with hematologic disorders.
abstract: A clinicoepidemiologic study was undertaken to investigate an apparent increase in frequency of nosocomial invasive filamentous fungal disease (NIFFD) in adult patients with acute leukemia hospitalized during a period of hospital construction, and to determine if a relationship existed between the construction activity and the acquisition of NIFFD. The first study goal, to determine the incidence of NIFFD before and during construction, was approached by calculation of incidence rates of NIFFD in patients with acute leukemia, comparing 1982 and 1983 (a baseline period free of construction) to 1986 (a year when construction activity was at its peak). The second study goal, to identify risk factors for the development of NIFFD, was accomplished by reviewing the autopsy records of all patients with underlying hematologic disorders accompanied by granulocytopenia who died in our hospital from 1982 through 1986. Patients with and without autopsy evidence of NIFFD were then compared by univariate and multivariate (logistic regression) analysis to identify potential risk factors for the acquisition of NIFFD. The incidence of NIFFD in patients with acute leukemia hospitalized during the period of hospital construction was significantly increased when compared to a baseline period without construction (11 per 139 versus 4 per 333, p less than .001). Review of all granulocytopenic patients autopsied over the five-year interval 1982 through 1986 revealed duration of granulocytopenia and hospitalization during construction to be risk factors for NIFFD by univariate analysis (p less than .005). Logistic regression showed duration of granulocytopenia to be highly significant independent risk factor (p less than .01) and construction activity to be a probable independent risk factor (p = .09).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Section on Infectious Disease, Cancer Center of Wake Forest University, Winston-Salem, North Carolina 27103.
authors.forename: S F
authors.initials: SF
authors.lastname: Weber
authors.forename: J E
authors.initials: JE
authors.lastname: Peacock
authors.forename: K A
authors.initials: KA
authors.lastname: Do
authors.forename: J M
authors.initials: JM
authors.lastname: Cruz
authors.forename: B L
authors.initials: BL
authors.lastname: Powell
authors.forename: R L
authors.initials: RL
authors.lastname: Capizzi
mesh_terms: D003428:Cross Infection / Q000209:etiology* / Q000517:prevention & control; D005260:Female; D006402:Hematologic Diseases / Q000150:complications*; D006746:Hospital Bed Capacity, 500 and over; D006749:Hospital Design and Construction; D006801:Humans; D008875:Middle Aged; D009181:Mycoses / Q000209:etiology* / Q000517:prevention & control; D009657:North Carolina; D012307:Risk Factors; D014691:Ventilation / Q000379:methods